Immunological mechanisms of contact hypersensitivity in mice
Tóm tắt
Christensen AD, Haase C. Immunological mechanisms of contact hypersensitivity in mice. APMIS 2012; 120: 1–27.
Contact hypersensitivity (CHS) is an animal model in which the immunological mechanisms of allergic contact dermatitis (ACD) in humans can be studied but is also widely used in the study of many basic immunological mechanisms. In CHS, a pre‐sensitized animal is re‐exposed to an antigen, thereby eliciting an immunological reaction at the site of antigen exposure. CHS consists of two phases: sensitization and elicitation phase. In the sensitization phase, the first contact of the skin with a hapten leads to binding of the hapten to an endogenous protein in the skin where they form hapten‐carrier complexes which are immunogenic. The hapten‐carrier complex is taken up by Langerhans cells (LCs) and dermal dendritic cells (dDCs) which migrate from the epidermis to the draining lymph node. Here, they present the haptenated peptides to naive T cells which are subsequently activated. The newly activated T cells proliferate and migrate out of the lymph node and into circulation. In the elicitation phase, re‐exposure of the skin to the hapten activates the specific T cells in the dermis and triggers the inflammatory process responsible for the cutaneous lesions. Originally CHS was regarded as being solely driven by T cells but recently other cell types such as B1 cells, natural killer (NK) T cells and NK cells have shown to mediate important functions during the response as well. Here, we have described the molecular and cellular pathways in the development of CHS and have focused on recent advances and novel knowledge in the understanding of the immunoregulatory mechanisms involved in CHS.
Từ khóa
Tài liệu tham khảo
Gaspari AA, 1991, Contact hypersensitivity, Curr Protoc Immunol, 4.2.1
Tsuji RF, 1996, Possible involvement of C5/C5a in the efferent and elicitation phases of contact sensitivity, J Immunol, 156, 4644, 10.4049/jimmunol.156.12.4644
Geba GP, 1996, Delayed‐type hypersensitivity in mast cell‐deficient mice: dependence on platelets for expression of contact sensitivity, J Immunol, 157, 557, 10.4049/jimmunol.157.2.557
Van Loveren H, 1984, Delayed‐type hypersensitivity is mediated by a sequence of two different T cell activities, J Immunol, 133, 2397, 10.4049/jimmunol.133.5.2397
Sullivan S, 1986, Induction and regulation of contact hypersensitivity by resident, bone marrow‐derived, dendritic epidermal cells: Langerhans cells and Thy‐1+ epidermal cells, J Immunol, 137, 2460, 10.4049/jimmunol.137.8.2460
Cumberbatch M, 1995, Tumour necrosis factor‐alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization, Immunology, 84, 31
Kondo S, 1996, Contribution of the CD28 molecule to allergic and irritant‐induced skin reactions in CD28 ‐/‐ mice, J Immunol, 157, 4822, 10.4049/jimmunol.157.11.4822
Xu H, 1997, Distinct roles for B7‐1 and B7‐2 determinants during priming of effector CD8+ Tc1 and regulatory CD4+ Th2 cells for contact hypersensitivity, J Immunol, 159, 4217, 10.4049/jimmunol.159.9.4217
Xu H, 1997, Development of effector CD8 + T cells in contact hypersensitivity occurs independently of CD4+ T cells, J Immunol, 158, 4721, 10.4049/jimmunol.158.10.4721
Riemann H, 1996, Neutralization of IL‐12 in vivo prevents induction of contact hypersensitivity and induces hapten‐specific tolerance, J Immunol, 156, 1799, 10.4049/jimmunol.156.5.1799
Muller G, 1995, IL‐12 as mediator and adjuvant for the induction of contact sensitivity in vivo, J Immunol, 155, 4661, 10.4049/jimmunol.155.10.4661
Hope JC, 1995, Identification of dendritic cells as a major source of interleukin‐6 in draining lymph nodes following skin sensitization of mice, Immunology, 86, 441
Tang A, 1996, Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40‐ligand, J Immunol, 157, 117, 10.4049/jimmunol.157.1.117
Thomson JA, 1993, Contact sensitization to oxazolone: involvement of both interferon‐gamma and interleukin‐4 in oxazolone‐specific Ig and T‐cell responses, Immunology, 78, 185
Meuer S, 1981, Platelet‐serotonin release by C3a and C5a: two independent pathways of activation, J Immunol, 126, 1506, 10.4049/jimmunol.126.4.1506
McHale JF, 1999, Vascular endothelial cell expression of ICAM‐1 and VCAM‐1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF‐α, J Immunol, 162, 1648, 10.4049/jimmunol.162.3.1648
Cattani F, 2006, The role of CXCR2 activity in the contact hypersensitivity response in mice, Eur Cytokine Netw, 17, 42
Askenase PW, 1972, Contact sensitivity to oxazolone in the mouse. VIII. Demonstration of several classes of antibody in the sera of contact sensitized and unimmunized mice by a simplified antiglobulin assay, Immunology, 23, 289
D’Ambrosio D, 1998, Selective up‐regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells, J Immunol, 161, 5111, 10.4049/jimmunol.161.10.5111
Grabbe S, 1995, Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity, J Immunol, 155, 4207, 10.4049/jimmunol.155.9.4207
Dubois B, 2003, CD4+ CD25+ T cells as key regulators of immune responses, Eur J Dermatol, 13, 111
Enk AH, 1992, Identification and induction of keratinocyte‐derived IL‐10, J Immunol, 149, 92, 10.4049/jimmunol.149.1.92
Salerno A, 1995, Interleukin‐4 is a critical cytokine in contact sensitivity, Immunology, 84, 404
Gautam SC, 1992, Anti‐inflammatory action of IL‐4. Negative regulation of contact sensitivity to trinitrochlorobenzene, J Immunol, 148, 1411, 10.4049/jimmunol.148.5.1411
Wang B, 1999, Enhanced epidermal Langerhans cell migration in IL‐10 knockout mice, J Immunol, 162, 277, 10.4049/jimmunol.162.1.277
Jin H, 2009, IL‐21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice, J Clin Invest, 119, 47
Wang B, 1997, Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75, J Immunol, 159, 6148, 10.4049/jimmunol.159.12.6148
Steeber DA, 1999, Leukocyte entry into sites of inflammation requires overlapping interactions between the L‐selectin and ICAM‐1 pathways, J Immunol, 163, 2176, 10.4049/jimmunol.163.4.2176
Catalina MD, 1999, Selective requirements for leukocyte adhesion molecules in models of acute and chronic cutaneous inflammation: participation of E‐ and P‐ but not L‐selectin, Blood, 93, 580, 10.1182/blood.V93.2.580